Member Article

Chase Templeton Group secure investment

Private medical insurance company, Chase Templeton Group have secured investment from Manchester’s Palatine Private Equity.

The investment comes from the second round of Palatine’s fund, and will go towards growth of the 50-strong company with offices in Blackburn and Bridgwater.

Kevin Amphlett, chairman of Chase Templeton Group, said: “It became clear that attracting professional investment was the most efficient way of fuelling our ambitious growth plans. After considering various offers, we chose the team at Palatine because of their enthusiastic approach and deep understanding of our buy-and-build strategy.

“These are exciting times ahead for the business. Although our hunger for growth is strong, we will continue to remain selective in our choice of acquisitions and true to our business model. We will announce another acquisition in the next few weeks. Organic growth is also an important aspect of our future strategy and a focus on new initiatives and bespoke product offerings is planned in the coming months.”

Ed Fazakerley, partner at Palatine Private Equity, will join the board of the company as a non-executive.

He said: “Kevin and the Chase management team have grown the business to become a leading player in a very competitive environment. The investment will allow the business to continue with its buy-and-build strategy and will further strengthen its position in the market. We are excited about working with such an ambitious team and a great business.”

Chase Templeton were advised by Matt Beckley of DTW Corporate Finance with legal advice from Shoosmiths’ Manchester team, led by Mark Dawson, Karen Procter and Alex Lilley.

This was posted in Bdaily's Members' News section by Tom Keighley .